Document Detail


Is early anticoagulation necessary after biological aortic valve replacement?
MedLine Citation:
PMID:  18068239     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Early antithrombotic therapy after biological aortic valve replacement (AVR) is controversial. The aim of this study was to determine the rate of thromboembolic events (TE) without anticoagulation treatment during the first 3 months after surgery. Out of 143 consecutive patients who underwent biological AVR from January 1998 to December 2004, 127 patients who did not receive anticoagulation were included (89%). Events during the first 3 months after surgery included: 2 strokes (1.5%), 2 major bleedings (1.5%) and 9 deaths (7%) (none of them due to TE). In conclusion, the management of patients without antithrombotic treatment after biological AVR seems to be safe due to a low rate of TE.
Authors:
Mariano Noel Benzadón; Jorge Mario Thierer; Marcelo Trivi; Mariano Vrancic; Sebastian Fieg; Fernando Piccinini; Guillermo Vaccarino; Daniel Navia
Related Documents :
2794919 - Retrospective analysis of 97 patients with infective endocarditis seen over the past 8 ...
2709859 - The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy. experienc...
16432119 - Long-term results of triple-valve procedure.
2443029 - Total and near-total gastrectomy for gastric cancer in patients over 70 years of age.
1810549 - Bioprosthetic valve durability in the elderly: the second decade.
19110809 - Early echocardiographic evaluation following percutaneous implantation with the self-ex...
10826419 - Severe steroid-unresponsive ulcerative colitis: outcomes of restorative proctocolectomy...
22028389 - Tumor pseudoprogression following radiosurgery for vestibular schwannoma.
24552209 - Holmium laser enucleation and photoselective vaporization of the prostate for patients ...
Publication Detail:
Type:  Comparative Study; Letter     Date:  2007-12-18
Journal Detail:
Title:  International journal of cardiology     Volume:  128     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-08-04     Completed Date:  2009-02-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  422-3     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Anticoagulants / therapeutic use*
Aortic Valve / drug effects,  pathology,  surgery*
Female
Follow-Up Studies
Heart Valve Prosthesis / adverse effects
Heart Valve Prosthesis Implantation / adverse effects*
Humans
Male
Middle Aged
Postoperative Complications / epidemiology,  prevention & control
Retrospective Studies
Time Factors
Chemical
Reg. No./Substance:
0/Anticoagulants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  HIV and Long QT syndrome--cause or coincidence.
Next Document:  Standard measures of right ventricular function assessment in adult patients with acute sickle cell ...